Electronic Inspection Platform for Remote Regulatory Compliance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Regulatory bodies worldwide present complex and diverse regulatory requirements for pharmaceuticals, biologics, medical devices, and food products, making it challenging for companies to understand and comply with international standards, especially due to the difficulty in collecting and analyzing data for quality inspections, which can be hindered by travel restrictions.
Innovation Solution
A software system, referred to as 'eQip' or 'ieQip', provides a paperless, electronic quality inspection platform that compiles regulations from various global regulatory bodies into a single platform, allowing for remote or on-site inspections, using artificial intelligence to assist in data collection and analysis, and enabling multiple auditors to collaborate efficiently.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If on-site inspections are performed for quality checks, then inspection quality and regulation adherence can be ensured, but travel restrictions hinder the ability to perform inspections and the process becomes time-consuming
Solution Approach 1:
The system creates a virtual copy of the on-site inspection process through remote video conferencing and digital document review. Inspectors can conduct quality checks and regulation adherence assessments remotely by accessing digital copies of facility data, production records, and quality control documentation, eliminating the need for physical travel while maintaining inspection reliability
Solution Approach 2:
The inspection management system acts as an intermediary platform that connects remote inspectors with inspected facilities. The system facilitates real-time communication, document exchange, and collaborative review processes, enabling quality inspections to proceed remotely without compromising thoroughness or reliability
2Adaptability or versatility
If regulations from multiple regulatory bodies are compiled and analyzed, then global market access and compliance understanding are improved, but data collection and analysis become difficult and time-consuming
Solution Approach 1:
The system merges regulatory requirements from multiple international regulatory bodies (FDA, EMA, PMDA, etc.) into a single integrated platform. By consolidating diverse regulatory data sources and standardizing their presentation, the system enables companies to understand and comply with multiple jurisdictions' requirements simultaneously, improving global market adaptability while reducing the time needed to collect and analyze separate regulatory datasets
Solution Approach 2:
The inspection management system provides universal functionality that accommodates multiple regulatory frameworks through a single interface. The system can configure inspection protocols, checklists, and evaluation criteria to match different regulatory requirements, allowing the same platform to serve various global markets without requiring separate data collection processes for each jurisdiction
Data Source
AI summary
Provided herein are systems and methods for collaboratively assessing adherence to pharmaceutical regulations and performing inspections of a pharmaceutical facility, operable on a system including a computing device having a database server, a processor, a display, and a camera, wherein the systems and methods include performing data pulls by pulling information from a plurality of sources, pulling regulatory guidelines from a plurality of official regulatory bodies, and checking for updates to the information and the regulatory guidelines at predetermined intervals; such that the data received from the data pulls is used to assess the adherence to pharmaceutical regulations, perform the inspections, and answer input queries from a user related to the information and the regulatory guidelines.